Valion Bio, Inc. (VBIO) Gross margin 2021–2024
Valion Bio, Inc. (VBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
0.3%FY2024 · since FY2021: -3.0% → 0.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 0.3% | -24.1 pp |
| FY2023 | 24.4% | +8.2 pp |
| FY2022 | 16.3% | +19.3 pp |
| FY2021 | -3.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice